For the past 20 years, Innovaderm has been offering clinical research services of superior quality, serving its partners in their journey to discover new dermatology therapies and ultimately, help patients gain access to new and safe treatments.
To offer dermatology clinical research services of superior quality in order to rapidly generate precise and reliable data. Our efficient and professional staff maintains a pleasant and safe environment for our clinical research subjects.
Team spirit is the willingness to cooperate as a team and support one another for the success of our client’s projects. It is also about open communication, the sharing of knowledge and experiences, to promote self-development and the development of others.
Integrity is at the center of our everyday work. We are constantly striving to maintain the highest ethical standards, quality control and compliance with major worldwide regulatory health institutions.
Engagement is the enthusiasm and the passion that every employee expresses towards dermatology, clinical research and most importantly our clients and patients.
In 2000, Innovaderm began its activities as a clinical research site specialized in dermatology. Innovaderm has quickly built a strong reputation for the quality of its clinical research, the achievement of subject enrollment objectives and the care offered to its study participants.
In 2004, Innovaderm initiated strategic partnerships with research centers in the United States and Canada to offer its sponsors access to other high-quality dermatology sites. Since then, Innovaderm has built an excellent database of collaborating sites in North America.
In 2007, Innovaderm expanded its activities to include Clinical Research Organization (CRO) services for studies in dermatology. Our company offers a unique combination of a full-service CRO with advanced scientific capabilities and expert clinical site network.
Innovaderm is internationally renowned for its numerous research studies on psoriasis, acne and atopic dermatitis as well as for studies involving biologics and photodynamic therapy (PDT). Over 64% of our team comes from a life sciences background and over 55% has a postgraduate degree (Master, PhD and MD).
Robert Bissonnette, MD, FRCPC
Founder and CEO
Dr. Robert Bissonnette is the chief executive officer and medical director at Innovaderm, a company he established in 2000. For more than 20 years, Dr. Bissonnette has dedicated his efforts towards the advancement of dermatology research. Dr. Bissonnette has conducted nearly 200 studies ranging from proof-of-concept to phase III studies. As a Key Opinion Leader, he has extensive knowledge of clinical dermatology, clinical research, the dermatology market and is a great asset to our clients as he is able to offer a large perspective in the dermatology research field. He published more than 140 articles and book chapters and gives lectures on various aspects of dermatology at various national and international meetings. After graduating in Medicine from the University of Montreal, he completed his residency training in dermatology at the University of Montreal and his clinical research training at McGill University and the University of British Columbia. Dr. Bissonnette is a board-certified dermatologist and was an associate professor of dermatology at the University of Montreal until 2004. He is regularly solicited to participate on advisory board meetings for his expert opinion on clinical product development. Dr. Bissonnette is internationally renowned for his clinical expertise in atopic dermatitis and psoriasis.
Anne Marie Gaulin
Anne Marie Gaulin serves as the chief business officer at Innovaderm, overseeing business growth and facilitating the liaison between sponsors and our operational team for clinical research projects. Anne Marie joined Innovaderm as a director of business development in 2009. Since then, Anne Marie has contributed to the success and growth of the company by managing sales, marketing, the recruitment center, the CRO operations, the commercial development and she is also responsible for strategic planning. Her knowledge of dermatology clinical trials and more than 25 years of experience in the pharmaceutical industry is a great asset to our clients. Prior to joining Innovaderm, Anne Marie held a business development position at Cirion Biopharma, a central laboratory located in the Montreal area, an Operational management position at Alcan packaging, a company specialized in the packaging of pharmaceuticals and different sales and marketing positions in the pharmaceutical industry, including Rhône-Poulenc Rorer, now Sanofi and Sandoz Consumer Health, a division of Novartis.
Sanjay Machado, MD
Dr. Sanjay Machado recently joined Innovaderm as the chief operating officer to oversee the clinical operations. He graduated with a Medical degree (MD) in family medicine and held a private practice in India. Sanjay has over 22 years of experience with multinational biopharmaceutical, CRO, bioequivalence, phase I and site management organizations. He founded Venn Life Sciences, a multinational CRO now trading on the London Stock Exchange and served as its chief operating officer since its inception. He executed 8 CRO acquisitions internationally including their integration with parent companies. The experience of Sanjay with pharmaceutical investigational products, generic drugs, medical devices, imaging studies, Post-Approval Clinical and Epidemiological Studies (PACES) and investigator-initiated studies in several therapeutic areas from phase I to IV are invaluable to our client’s success.
Yves Glaude joined Innovaderm in February 2020. As Chief Financial Officer Yves is responsible for the overall financial strategy and direction, business support, financial planning and analysis, treasury, risk management and assessment of organic development and acquisition opportunities. Yves has more than 30 years of experience in financial management with large and growing mid-size companies in the life sciences, business services and technology sectors. Specifically, Yves has more than 15 years of experience in financial management in various CROs providing services in all stages of drug development, including drug discovery, preclinical research, early and late phase of clinical research. He has been actively involved in managing the growth of companies including business acquisitions, organic growth, broadening the range of services offered, and differentiation strategies. He is recognized as a leading finance professional, using his diverse experience to implement best practices in corporate financial governance. Yves is a Chartered Professional Accountant (CPA) by training, with a degree from HEC Montréal.
VP, CRO Operations
Julie Bédard joined Innovaderm in 2014 in the role of Vice President, CRO Operations and has been overseeing all CRO operations services ever since. Prior to joining Innovaderm, Julie was holding the position of managing director of the Canadian office of a global mid-size CRO as well as leading the clinical trial management and monitoring group in the position of VP, Clinical trial operations for North America. She has over 22 years of experience in clinical research in a CRO environment including project management, clinical monitoring, clinical trial management and executive management. Julie holds a master’s degree in nutrition science from the University of Montreal.
Our team is fully invested in the development of your projects, striving to help you achieve success in your mission of improving patients’ lives. Our teams are devoted to applying custom solutions to the complex and ever-changing landscape of clinical research and development.
To overcome these challenges, our team, with their life-sciences background, is trained in dermatology and understands the intricacies of your clinical program. In addition, our Quality Assurance unit is dedicated to supporting your project throughout each step of its execution, endeavoring to meet high-standard quality controls.
Our continuous and rapid growth positions us to tackle the most difficult aspects of your dermatology clinical trials. We are always aiming to exceed your expectations, contact us to learn more about our capabilities.
We are located in Montreal, one of the largest and most multicultural cities in North America. Montreal is internationally renowned for its world-class education and for its large pool of diverse talent. Many of the world’s top research and technology institutions are located in Montreal, making it a remarkable science and innovation hub.
With its significant number of teaching hospitals, phase I units, laboratories and access to a large pool of research volunteers coming from diverse ethnic backgrounds, Montreal is a significant contributor to clinical research.
We have modern, state-of-the-art facilities that are conveniently located in downtown Montreal, 30 minutes away from the Montreal-Trudeau International Airport.